Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Journal of Public Health Management and Practice : JPHMP
|
July 24, 2015
High School Completion Programs: A Community Guide Systematic Economic Review
Shuli Qu, Sajal K Chattopadhyay, Robert A Hahn, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 25, 2020
Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
Jiujie Cui, Xiaochen Zhang, Shuli Qu, et al.
Current Medical Research and Opinion
|
August 31, 2019
Lixisenatide versus insulin glulisine on top of insulin glargine in patients with type 2 diabetes mellitus: a cost-per-responder analysis in China
Peng Men, Chaoyun Li, Suodi Zhai, et al.
Journal of Comparative Effectiveness Research
|
September 4, 2019
Comparative clinical effects and cost-effectiveness of maximum androgen blockade, docetaxel with androgen deprivation therapy and ADT alone for the treatment of mHSPC in China
Maobai Liu, Shuli Qu, Yanjun Liu, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
Peng Men, Shuli Qu, Wenting Luo, et al.
Annals of Translational Medicine
|
May 16, 2022
Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
Zhenhua Wang, Ruixiaotong Sun, Yanan Sheng, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 21, 2020
Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost-Utility Analysis
Peng Men, Shuli Qu, Zhenqiang Song, et al.
Clinical Drug Investigation
|
November 28, 2019
A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting
Yun Bao, Gang Zhao, Shuli Qu, et al.
Cost Effectiveness and Resource Allocation : C/E
|
December 25, 2019
Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis
Xin Hu, Shuli Qu, Xingxing Yao, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 16, 2020
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China
Zhan-Miao Yi, Peng Men, Shuli Qu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Journal of Public Health Management and Practice : JPHMP
|
July 24, 2015
High School Completion Programs: A Community Guide Systematic Economic Review
Shuli Qu, Sajal K Chattopadhyay, Robert A Hahn, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
September 25, 2020
Cost-effectiveness analysis of nab-paclitaxel plus gemcitabine versus folfirinox in the treatment of metastatic pancreatic cancer in china
Jiujie Cui, Xiaochen Zhang, Shuli Qu, et al.
Current Medical Research and Opinion
|
August 31, 2019
Lixisenatide versus insulin glulisine on top of insulin glargine in patients with type 2 diabetes mellitus: a cost-per-responder analysis in China
Peng Men, Chaoyun Li, Suodi Zhai, et al.
Journal of Comparative Effectiveness Research
|
September 4, 2019
Comparative clinical effects and cost-effectiveness of maximum androgen blockade, docetaxel with androgen deprivation therapy and ADT alone for the treatment of mHSPC in China
Maobai Liu, Shuli Qu, Yanjun Liu, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2019
Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
Peng Men, Shuli Qu, Wenting Luo, et al.
Annals of Translational Medicine
|
May 16, 2022
Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
Zhenhua Wang, Ruixiaotong Sun, Yanan Sheng, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 21, 2020
Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost-Utility Analysis
Peng Men, Shuli Qu, Zhenqiang Song, et al.
Clinical Drug Investigation
|
November 28, 2019
A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting
Yun Bao, Gang Zhao, Shuli Qu, et al.
Cost Effectiveness and Resource Allocation : C/E
|
December 25, 2019
Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis
Xin Hu, Shuli Qu, Xingxing Yao, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 16, 2020
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China
Zhan-Miao Yi, Peng Men, Shuli Qu, et al.
Page
of 3